CAS: 1073-21-8; 2,4-Dimethylpyridin-3-Amine

相似化合物

1074-76-6 1193-71-1 3430-10-2

上下游产品

CAS号1074-76-6 2,4-二甲基-3-硝基吡啶 | CAS号55314-30-2 2,4-二甲基烟酸 | CAS号89793-08-8 6-氯-2,4-二甲基-3-硝基吡啶 | CAS号108-47-4 2,4-二甲基吡啶 | CAS号22934-24-3 4,6-二甲基-5-硝基-2(... | CAS号897733-12-9 6-溴-2,4-二甲基吡啶-3-胺 | CAS号27296-76-0 2,4-二甲基-3-羟基吡啶

📜2,4-二甲基吡啶置于盐酸,Palladium On Activated Charcoal,硫酸,Potassium Nitrate体系中,化学反应生成2,4-二甲基-3-氨基吡啶
参考文献:Furukawa,Yakugaku Zasshi/journal Of The Pharmaceutical Society Of Japan,1956,Vol. 76,P. 900
标题:Furukawa,Yakugaku Zasshi/journal Of The Pharmaceutical Society Of Japan,1956,Vol. 76,P. 900

专利信息

专利号:US-8742028-B2
优先权日:2009-05-06
标 题:Solid support for Fmoc-solid phase synthesis of peptide acids
发明人：SRIVASTAVA KRIPA S; DAVIS MATTHEW R
权利人:SRIVASTAVA KRIPA S; DAVIS MATTHEW R; MALLINCKRODT LLC
摘要:The present invention provides a solid support for Fmoc-solid phase synthesis of peptides. In particular, the solid supports of the invention may be utilized to produce peptide acids.

专利号:US-2010286359-A1
优先权日:2009-05-06
标题:Solid Support for FMOC-Solid Phase Synthesis of Peptide Acids

专利号:US-6617444-B1
优先权日:1999-06-30
标题 :Dinucleotide tetraphosphate crystals
发明人：MORI KENYA; MIYASHITA TAKANORI; MAEDA HIDEAKI; SATO HIROSHI; NODA YUTAKA
权利人:YAMASA CORP
摘要:The present invention is directed to crystals of P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-)tetraphosphate (dCP4U) or a salt thereof and to a process for producing the crystals. The present invention also provides a process for producing dCP4U involving reacting uridine 5'-monophosphate (UMP), 2'-deoxycytidine 5'-monophosphate (dCMP), diphenyl phosphorochloridate (DPC), and pyrophosphate (PPi). The crystals of dCP4U obtained through the process according to the present invention have high purity and high stability and no hygroscopicity as compared with a freeze-dried product, and thereby serve as a useful raw material for preparing a pharmaceutical. The process for producing dCP4U according to the present invention permits use of inexpensive UMP as a raw material and realizes high yield. Thus, the process is suitable for large-scale synthesis of dCP4U.

专利号:WO-2020102730-A1
优先权日:2018-11-16
标 题:Improved synthesis of key intermediate of kras g12c inhibitor compound

专利号:CN-109503462-A
优先权日:2019-01-21
标 题:A new method for the synthesis of tofacitinib intermediate (3R,4R)-N,4-dimethyl-1-benzyl-3-piperidinamine and its oxalate hydrate

专利号:EP-3880670-B1
优先权日:2018-11-16
标题 :Improved synthesis of key intermediate of kras g12c inhibitor compound